Showing 17,761 - 17,780 results of 46,043 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.75s Refine Results
  1. 17761

    The efficacy of topical 8% capsaicin patches for the treatment of postsurgical neuropathic pain: a systematic review by Brandon Goodwin (20328988)

    Published 2024
    “…All studies that investigated neuropathic pain area denote a decrease in pain size, with some denoting a continued reduction with subsequent application.…”
  2. 17762
  3. 17763

    Created with BioRender.com. by Simone Schiavo (15999287)

    Published 2024
    “…Thirteen patients had HFpEF (mean LVEF 55 ± 7%), and seven patients had HFrEF (mean LVEF 35 ± 8%) as well as concomitantly decreased right ventricle function (n = 5), moderate/severe tricuspid regurgitation (n = 3), or pulmonary hypertension (n = 5). …”
  4. 17764

    Hyperbaric oxygen therapy details. by Simone Schiavo (15999287)

    Published 2024
    “…Thirteen patients had HFpEF (mean LVEF 55 ± 7%), and seven patients had HFrEF (mean LVEF 35 ± 8%) as well as concomitantly decreased right ventricle function (n = 5), moderate/severe tricuspid regurgitation (n = 3), or pulmonary hypertension (n = 5). …”
  5. 17765

    Prenatal medication use in a prospective pregnancy cohort by pre-pregnancy obesity status by Yassaman Vafai (10294851)

    Published 2021
    “…A total of 17 classes of medications were identified. …”
  6. 17766

    DataSheet_1_A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in health... by Richard T. Kenney (15289313)

    Published 2024
    “…</p>Methods<p>SB102 (NCT05408572) focused on safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) endpoints. SON-1010 at 50-300 ng/kg or placebo administered subcutaneously on day 1 was studied at a ratio of 6:2, starting with two sentinels; participants were followed through day 29. …”
  7. 17767
  8. 17768

    UBKIs possess broad antiviral activity, are effective in primary cells, and impose a barrier against resistance development. by Markus Lesch (6475409)

    Published 2019
    “…The experiment was terminated after 8 passages. Data represent mean ± SD of technical replicates.</p>…”
  9. 17769

    Data_Sheet_1_Brain cortical alterations in COVID-19 patients with neurological symptoms.docx by Gretel Sanabria-Diaz (436165)

    Published 2022
    “…II–III), with age, sex, MRI magnetic field strength, and total intracranial volume/mean thickness/total surface area as covariates. …”
  10. 17770

    Triple immunofluorescence labeling comparing both sarcomeric actin and VDAC expression in control versus MFN2 mutant mice. by Peter Bannerman (3373028)

    Published 2016
    “…Initially, note the selective expression of the mutant form of MFN2 in satellite cells of the mutant myofibers with occasion dissemination into the muscle fiber (white arrow-heads). Also note both the decreased intensity of sarcomeric actin immunolabelling in the mutant mice versus wild-type mice (compare A and B) and the relative disruption of striated myofibrillar distribution of VDAC positive mitochondria in mutant micrograph D versus C. …”
  11. 17771

    Effect of ACE inhibitors on the binding of a set of anti-ACE mAbs to blood ACE. by Maxim N. Petrov (118931)

    Published 2012
    “…Serum pooled from 30 healthy donors and diluted 1/5 in PBS (50 µl) was incubated with or without ACE inhibitors for 1 hour at 37oC and then was incubated overnight with microtiter plate coated with different anti-ACE mAbs (3 µg/ml) via goat-anti-mouse bridge. …”
  12. 17772

    In-Car Nocturnal Blue Light Exposure Improves Motorway Driving: A Randomized Controlled Trial by Jacques Taillard (125714)

    Published 2012
    “…<div><p>Prolonged wakefulness greatly decreases nocturnal driving performance. The development of in-car countermeasures is a future challenge to prevent sleep-related accidents. …”
  13. 17773
  14. 17774
  15. 17775
  16. 17776

    The impact of a CTL-based vaccine is dependent upon the extent to which it affects transmission potential. by Helen R. Fryer (194033)

    Published 2011
    “…One vaccine (circles, A and B) considerably reduces transmission probability by a factor of 25 (), but restores life expectancy to its normal value (50 years; years<sup>−1</sup>). …”
  17. 17777
  18. 17778

    Inhibition of growth and proliferation of MCF7 cells. by Fazal Khan (3149331)

    Published 2016
    “…These decreases in inhibitions were statistically significant. …”
  19. 17779

    Short-term knockdown of <i>Vg-like A</i> reduced brood care behavior. by Philip Kohlmeier (3293766)

    Published 2018
    “…A down-regulation of <i>Vg-like A</i> decreased brood care behavior in young workers and brood carers but not in other castes. …”
  20. 17780